1-4 of 4
Andrei Shustov
Close
Sort by
Journal Articles

Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses

Edward L. Briercheck, Shashidhar Ravishankar, Elshafa Hassan Ahmed, César Camilo Carías Alvarado, Juan Carlos Barrios Menéndez, Oscar Silva, Elizabeth Solórzano-Ortiz, Marcos Mauricio Siliézar Tala, Philip Stevenson, Yuexin Xu, Anthony Wilder Wohns, Daniel Enriquez-Vera, Carlos Barrionuevo, Shan-Chi Yu, Aharon G. Freud, Christopher Oakes, Christoph Weigel, David M. Weinstock, Haley L. Klimaszewski, Apollinaire Ngankeu, Nora Mutalima, Gabriela Samayoa-Reyes, Robert Newton, Rosemary Rochford, Fabiola Valvert, Yasodha Natkunam, Andrei Shustov, Robert A. Baiocchi, Edus H. Warren
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3731–3744.
https://doi.org/10.1182/bloodadvances.2023012461
Published: 2024
Includes: Supplemental data
Journal Articles

Role of stem cell transplant in CD30 + PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Clinical Trials & Observations
Kerry J. Savage, Steven M. Horwitz, Ranjana Advani, Jacob Haaber Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser, Onder Alpdogan, Cheolwon Suh, Kensei Tobinai, Andrei Shustov, Marek Trneny, Sam Yuen, Pier Luigi Zinzani, Lorenz Trümper, Tim Ilidge, Owen A. O’Connor, Barbara Pro, Harry Miao, Veronica Bunn, Keenan Fenton, Michelle Fanale, Markus Puhlmann, Swaminathan Iyer
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5550–5555.
https://doi.org/10.1182/bloodadvances.2020003971
Published: 2022
Includes: Supplemental data
Journal Articles

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project

Clinical Trials & Observations
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, Monica Bellei, Young Hyeh Ko, Martina Manni, Tetiana Skrypets, Steven M. Horwitz, Carmino Antonio De Souza, John A. Radford, Sabela Bobillo, Maria Virginia Prates, Andrés J. M. Ferreri, Carlos Chiattone, Michele Spina, Julie M. Vose, Annalisa Chiappella, Daniele Laszlo, Dario Marino, Caterina Stelitano, Massimo Federico
Journal: Blood Advances
Blood Adv (2021) 5 (3): 640–648.
https://doi.org/10.1182/bloodadvances.2020001581
Published: 2021
Journal Articles

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study

Clinical Trials & Observations
Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1167–1180.
https://doi.org/10.1182/bloodadvances.2016001925
Published: 2017
Includes: Supplemental data